OBJECTIVES: To determine if there is predilection for any specific anatomical location of positive surgical margins (PSMs) after radical prostatectomy (RP) for prostate cancer in obese men, as previous studies found that obesity was associated with an increased risk of PSMs. PATIENTS AND METHODS: We analysed retrospectively 1434 men treated with RP between 1989 and 2007 within the Shared Equal Access Regional Cancer Hospital database. The association between increased body mass index (BMI) and overall and site-specific PSMs was assessed using multivariate logistic regression. RESULTS: After adjusting for several preoperative clinical and pathological characteristics, a higher BMI was associated with an increased risk of PSMs both overall and at all specific anatomical locations (all P <or= 0.007). For mildly obese men, this risk was very similar across all anatomical sites (44-78% increased risk relative to men of normal weight). When BMI was coded as a continuous variable, the odds ratio for the risk of overall PSMs or at any specific locations was nearly identical at 1.05-1.06. Among men with a BMI of >or=35 kg/m2, there was more variation, with the highest excess risk of PSMs at the bladder neck and apex. CONCLUSIONS: Obesity was associated with an increased risk of overall PSMs and at all anatomical locations. Although the excess risk of PSMs was similar across all anatomical locations, there was a suggestion of a higher risk of apical margins among the most obese men, which if validated, further supports the importance of the apical dissection in all men and suggests added difficulty in obese patients.
OBJECTIVES: To determine if there is predilection for any specific anatomical location of positive surgical margins (PSMs) after radical prostatectomy (RP) for prostate cancer in obesemen, as previous studies found that obesity was associated with an increased risk of PSMs. PATIENTS AND METHODS: We analysed retrospectively 1434 men treated with RP between 1989 and 2007 within the Shared Equal Access Regional Cancer Hospital database. The association between increased body mass index (BMI) and overall and site-specific PSMs was assessed using multivariate logistic regression. RESULTS: After adjusting for several preoperative clinical and pathological characteristics, a higher BMI was associated with an increased risk of PSMs both overall and at all specific anatomical locations (all P <or= 0.007). For mildly obesemen, this risk was very similar across all anatomical sites (44-78% increased risk relative to men of normal weight). When BMI was coded as a continuous variable, the odds ratio for the risk of overall PSMs or at any specific locations was nearly identical at 1.05-1.06. Among men with a BMI of >or=35 kg/m2, there was more variation, with the highest excess risk of PSMs at the bladder neck and apex. CONCLUSIONS:Obesity was associated with an increased risk of overall PSMs and at all anatomical locations. Although the excess risk of PSMs was similar across all anatomical locations, there was a suggestion of a higher risk of apical margins among the most obesemen, which if validated, further supports the importance of the apical dissection in all men and suggests added difficulty in obesepatients.
Authors: Carmen Rodriguez; Stephen J Freedland; Anusila Deka; Eric J Jacobs; Marjorie L McCullough; Alpa V Patel; Michael J Thun; Eugenia E Calle Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-12-19 Impact factor: 4.254
Authors: Sameer A Siddiqui; Brant A Inman; Shomik Sengupta; Jeffrey M Slezak; Eric J Bergstralh; Bradley C Leibovich; Horst Zincke; Michael L Blute Journal: Cancer Date: 2006-08-01 Impact factor: 6.860
Authors: Stephen J Freedland; Kelly A Grubb; Sindy K Yiu; Matthew E Nielsen; Leslie A Mangold; William B Isaacs; Jonathan I Epstein; Alan W Partin Journal: J Urol Date: 2005-11 Impact factor: 7.450
Authors: William W Bassett; Matthew R Cooperberg; Natalia Sadetsky; Stefanie Silva; Janeen DuChane; David J Pasta; June M Chan; Jason W Anast; Peter R Carroll; Christopher J Kane Journal: Urology Date: 2005-11 Impact factor: 2.649
Authors: Stephen J Freedland; Elizabeth A Platz; Joseph C Presti; William J Aronson; Christopher L Amling; Christopher J Kane; Martha K Terris Journal: J Urol Date: 2006-02 Impact factor: 7.450
Authors: Robert J Hamilton; William J Aronson; Joseph C Presti; Martha K Terris; Christopher J Kane; Christopher L Amling; Stephen J Freedland Journal: Cancer Date: 2007-11-15 Impact factor: 6.860
Authors: Nicholas J Fitzsimons; Leon L Sun; Philipp Dahm; Judd W Moul; John Madden; Tong J Gan; Stephen J Freedland Journal: Urology Date: 2007-12 Impact factor: 2.649
Authors: James A Eastham; Kentaro Kuroiwa; Makoto Ohori; Angel M Serio; Alex Gorbonos; Norio Maru; Andrew J Vickers; Kevin M Slawin; Thomas M Wheeler; Victor E Reuter; Peter T Scardino Journal: Urology Date: 2007-11 Impact factor: 2.649
Authors: Stephen J Freedland; William J Aronson; Christopher J Kane; Joseph C Presti; Christopher L Amling; David Elashoff; Martha K Terris Journal: J Clin Oncol Date: 2003-12-22 Impact factor: 44.544
Authors: Michael S Leapman; Stephen J Freedland; William J Aronson; Christopher J Kane; Martha K Terris; Kelly Walker; Christopher L Amling; Peter R Carroll; Matthew R Cooperberg Journal: J Urol Date: 2016-06-25 Impact factor: 7.450
Authors: A C Vidal; L E Howard; S X Sun; M R Cooperberg; C J Kane; W J Aronson; M K Terris; C L Amling; S J Freedland Journal: Prostate Cancer Prostatic Dis Date: 2016-10-04 Impact factor: 5.554